---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-25-000027"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:11:03.592910+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Prestige Q1 revenue down 6.6%, misses; acquires Pillar5 for CAD 150M, cuts FY26 outlook

## Summary
- Revenue $249.5M (-6.6% YoY); diluted EPS $0.95 ($0.90 adjusted).
- Clear Eyes supply constraints drove North American OTC revenue down to $212.6M.
- Acquiring Pillar5 Pharma for CAD 150M cash; expected to close Q3 FY2026.
- FY2026 outlook cut: revenue now $1.10-1.115B, EPS $4.50-4.58 (from $4.70-4.82).
- Net debt ~$0.9B; leverage 2.4x; free cash flow guidance unchanged at $245M+.

## SEC filing metadata
- accession: 0001295947-25-000027
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000027/0001295947-25-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000027/pbh-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-25-000027
- JSON: https://secwatch.observer/filing/0001295947-25-000027.json
- Plain text: https://secwatch.observer/filing/0001295947-25-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.